ACCENDRA HEALTH INC (ACH) Stock Fundamental Analysis

NYSE:ACH • US6907321029

2.28 USD
-0.1 (-4.2%)
At close: Feb 12, 2026
2.28 USD
0 (0%)
After Hours: 2/12/2026, 8:26:57 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

ACH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. ACH has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACH has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ACH was profitable.
  • In the past year ACH has reported a negative cash flow from operations.
  • In multiple years ACH reported negative net income over the last 5 years.
  • In the past 5 years ACH always reported a positive cash flow from operatings.
ACH Yearly Net Income VS EBIT VS OCF VS FCFACH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

  • The Return On Assets of ACH (-33.21%) is worse than 84.31% of its industry peers.
  • ACH has a Return On Invested Capital of 10.36%. This is amongst the best in the industry. ACH outperforms 82.35% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACH is below the industry average of 9.04%.
  • The last Return On Invested Capital (10.36%) for ACH is above the 3 year average (6.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROIC 10.36%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ACH Yearly ROA, ROE, ROICACH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

  • ACH has a Operating Margin of 3.07%. This is comparable to the rest of the industry: ACH outperforms 56.86% of its industry peers.
  • ACH's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 26.13%, ACH is in line with its industry, outperforming 53.92% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACH has grown nicely.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 26.13%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
ACH Yearly Profit, Operating, Gross MarginsACH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ACH is creating some value.
  • The number of shares outstanding for ACH has been increased compared to 1 year ago.
  • The number of shares outstanding for ACH has been increased compared to 5 years ago.
  • Compared to 1 year ago, ACH has an improved debt to assets ratio.
ACH Yearly Shares OutstandingACH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ACH Yearly Total Debt VS Total AssetsACH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 1.40, we must say that ACH is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ACH (1.40) is worse than 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACC1.6
WACC6.48%
ACH Yearly LT Debt VS Equity VS FCFACH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ACH has a Current Ratio of 0.86. This is a bad value and indicates that ACH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.86, ACH is doing worse than 78.43% of the companies in the same industry.
  • ACH has a Quick Ratio of 0.86. This is a bad value and indicates that ACH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.84, ACH is not doing good in the industry: 74.51% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.84
ACH Yearly Current Assets VS Current LiabilitesACH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for ACH have decreased strongly by -22.29% in the last year.
  • The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
  • Looking at the last year, ACH shows a very negative growth in Revenue. The Revenue has decreased by -37.09% in the last year.
  • Measured over the past years, ACH shows a small growth in Revenue. The Revenue has been growing by 3.04% on average per year.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%

3.2 Future

  • ACH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.88% yearly.
  • The Revenue is expected to decrease by -26.97% on average over the next years. This is quite bad
EPS Next Y-31.69%
EPS Next 2Y-21.08%
EPS Next 3Y-7.93%
EPS Next 5Y-0.88%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.41%
Revenue Next 5Y-26.97%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACH Yearly Revenue VS EstimatesACH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
ACH Yearly EPS VS EstimatesACH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 1.77, the valuation of ACH can be described as very cheap.
  • Based on the Price/Earnings ratio, ACH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.67. ACH is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 2.41 indicates a rather cheap valuation of ACH.
  • Based on the Price/Forward Earnings ratio, ACH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • ACH is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.77
Fwd PE 2.41
ACH Price Earnings VS Forward Price EarningsACH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACH is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.96
ACH Per share dataACH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • ACH's earnings are expected to decrease with -7.93% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.08
EPS Next 2Y-21.08%
EPS Next 3Y-7.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ACH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACCENDRA HEALTH INC

NYSE:ACH (2/12/2026, 8:26:57 PM)

After market: 2.28 0 (0%)

2.28

-0.1 (-4.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners97.53%
Inst Owner Change0%
Ins Owners3.39%
Ins Owner ChangeN/A
Market Cap176.36M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Analysts50
Price Target3.77 (65.35%)
Short Float %12.45%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-6.28%
Max EPS beat(2)6.69%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)4.92%
EPS beat(12)10
Avg EPS beat(12)14.96%
EPS beat(16)13
Avg EPS beat(16)13.17%
Revenue beat(2)0
Avg Revenue beat(2)-57.22%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-39.15%
Revenue beat(4)0
Avg Revenue beat(4)-29.29%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-14.88%
Revenue beat(12)4
Avg Revenue beat(12)-9.26%
Revenue beat(16)7
Avg Revenue beat(16)-6.69%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.77
Fwd PE 2.41
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 4.96
EPS(TTM)1.29
EY56.58%
EPS(NY)0.95
Fwd EY41.52%
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS86.71
BVpS-5.55
TBVpS-23.57
PEG (NY)N/A
PEG (5Y)0.08
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROCE 13.12%
ROIC 10.36%
ROICexc 10.59%
ROICexgc 113.35%
OM 3.07%
PM (TTM) N/A
GM 26.13%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)N/A
ROICexgc(3y)17.92%
ROICexgc(5y)N/A
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score2
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 105.46%
Cap/Sales 3.93%
Interest Coverage 1.54
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.84
Altman-Z 1.4
F-Score2
WACC6.48%
ROIC/WACC1.6
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.69%
EPS Next 2Y-21.08%
EPS Next 3Y-7.93%
EPS Next 5Y-0.88%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.41%
Revenue Next 5Y-26.97%
EBIT growth 1Y-30.13%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year23.31%
EBIT Next 3Y6.96%
EBIT Next 5YN/A
FCF growth 1Y-170.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.82%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%

ACCENDRA HEALTH INC / ACH FAQ

What is the fundamental rating for ACH stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACH.


Can you provide the valuation status for ACCENDRA HEALTH INC?

ChartMill assigns a valuation rating of 6 / 10 to ACCENDRA HEALTH INC (ACH). This can be considered as Fairly Valued.


What is the profitability of ACH stock?

ACCENDRA HEALTH INC (ACH) has a profitability rating of 4 / 10.


Can you provide the financial health for ACH stock?

The financial health rating of ACCENDRA HEALTH INC (ACH) is 1 / 10.


Is the dividend of ACCENDRA HEALTH INC sustainable?

The dividend rating of ACCENDRA HEALTH INC (ACH) is 0 / 10 and the dividend payout ratio is 0%.